Effectiveness and feasibility of active and passive case detection in the visceral leishmaniasis elimination initiative in India, Bangladesh, and Nepal

American Journal of Tropical Medicine and Hygiene

Volumn 83, Issue 3, 2010, Pages 507-511

  Hirve, Siddhivinayak ^a   Singh, Shri Prakash ^b   Kumar, Narendra ^c   Banjara, Megha Raj ^d   Das, Pradeep ^c   Sundar, Shyam ^b   Rijal, Suman ^e   Joshi, Anand ^d   Kroeger, Axel ^f,g   Varghese, Beena ^h   Thakur, Chandreshwar Prasad ⁱ   Huda, M Mamun ^j   Mondal, Dinesh ^k  

^a KEM HOSPITAL   (India)

^b BANARAS HINDU UNIVERSITY   (India)

^c RAJENDRA MEMORIAL RESEARCH INSTITUTE OF MEDICAL SCIENCES   (India)

^d TRIBHUVAN UNIVERSITY   (Nepal)

^e B P KOIRALA INSTITUTE OF HEALTH SCIENCES   (Nepal)

^f WORLD HEALTH ORGANIZATION   (Switzerland)

^g LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^h PUBLIC HEALTH FOUNDATION OF INDIA   (India)

ⁱ Balaji Utthan Sanstha   (India)

^j ICDDRB Laboratory Sciences Division   (Bangladesh)

^k INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH   (Bangladesh)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; MILTEFOSINE;

ADULT; ARTICLE; BANGLADESH; DELAYED DIAGNOSIS; FEASIBILITY STUDY; FEMALE; HEALTH CARE COST; HEALTH PROGRAM; HUMAN; INDIA; LEISHMANIA BRAZILIENSIS; MAJOR CLINICAL STUDY; MALE; NEPAL; VISCERAL LEISHMANIASIS; INCIDENCE; MASS SCREENING;

BANGLADESH; FEASIBILITY STUDIES; HUMANS; INCIDENCE; INDIA; LEISHMANIASIS, VISCERAL; MASS SCREENING; NEPAL;

EID: 77957038386     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2010.09-0685     Document Type: Article

References (21)

1. World Health Organization, 2005. Regional Technical Advisory Group on Kala-azar Elimination. Report of the first meeting, Manesar, Haryana, 20-23 December 2004. New Delhi: Regional Office for South-East Asia.
2. World Health Organization, 2004. Regional Strategic Framework for Elimination of Kala-azar from the South-East Asia Region (2005-2015). New Delhi: Regional Office for South-East Asia.
3. Bern C, Chowdhury R, 2006. The epidemiology of visceral leishmaniasis in Bangladesh: prospects for improved control. Indian J Med Res 23: 275-288. (Pubitemid 43905569)
4. Joshi A, Narain JP, Prasittisuk C, Bhati R, Hashim G, Jorge A, Banjara M, Kroeger A, 2008. Can visceral leishmaniasis be eliminated from Asia? J Vector Borne Dis 45: 105-111. (Pubitemid 351809286)
5. Desjeux P, 1996. Leishmaniasis. Public health aspects and control. Clin Dermatol 14: 417-423. (Pubitemid 26327735)
6. Singh SP, Reddy DC, Rai M, Sundar S, 2006. Serious underreporting of visceral leishmaniasis through passive case reporting in Bihar, India. Trop Med Int Health 11: 899-905. (Pubitemid 43846450)
7. Bhattacharya SK, Sinha PK, Sundar S, Thakur CP, Jha TK, Pandey K, Das VR, Kumar N, Lal C, Verma N, Singh VP, Ranjan A, Verma RB, Anders G, Sindermann H, Ganguly NK, 2007. Phase 4 trial of miltefosine for the treatment of Indian visceral leishmaniasis. J Infect Dis 196: 591-598. (Pubitemid 47206107)
8. Sundar S, Jha TK, Thakur CP, Bhattacharya SK, Rai M, 2006. Oral miltefosine for the treatment of Indian visceral leishmaniasis. Trans R Soc Trop Med Hyg 100 (Suppl 1): S26-S33. (Pubitemid 44490165)
9. Sundar S, Chartterjee M, 2006. Visceral leishmaniasis-therapeutic modilities. Indian J Med Res 9: 26-39.
10. Sundar S, Reed SG, Singh VP, Kumar PC, Murray HW, 1998. Rapid accurate field diagnosis of Indian visceral leishmaniasis. Lancet 351: 563-565. (Pubitemid 28077563)
11. Sundar S, Pai K, Sahu M, Kumar V, Murray HW, 2002. Immunochromatographic striptest detection of anti-rK39 antibody in Indian visceral leishmaniasis. Ann Trop Med Parasitol 96: 19-23. (Pubitemid 34407192)
12. Sarker CB, Momem A, Jamal MF, Siddiqui NF, Chrowdhury KS, Rahman S, Talukder SI, 2003. Immunochromatographic (rK39) strip test in the diagnosis of visceral leishmaniasis in Bangladesh. Mymensingh Med J 12: 93-97.
13. Bern C, Jha SN, Joshi AB, Thakur GD, Bista MB, 2000. Use of the recombinant K39 dipstick test and the direct agglutination test in a setting endemic for visceral leishmaniasis in Nepal. Am J Trop Med Hyg 65: 153-157. (Pubitemid 32488353)
14. World Health Organization, 2007. Regional Technical Advisory Group on kala-azar elimination. Report of the Second Meeting, Kathmandu, Nepal, 20 October-2 November 2006. New Delhi: WHO SEARO, WHO Project: CCP CPC 050.
15. Sundar S, Mondal D, Rijal S, Bhattacharya S, Ghalib H, Kroeger A, Boelacrt M, Desjeux P, Richter-Airijoki H, Harms G, 2008. Implementation research to support the initiative on the elimination of kala-azar from Bangladesh, India and Nepal-the challenges for diagnosis and treatment. Trop Med Int Health 13: 2-5. (Pubitemid 351271390)
16. Mondal D, Singh SP, Kumar N, Joshi A, Sundar S, Das P, Siddivinayak H, Kroeger A, Boelaert M, 2009. Visceral leishmaniasis elimination program in India, Bangladesh and Nepal: reshaping the case finding/case management strategy. PLoS Negl Trop Dis 3: e355.
17. Chappuis F, Rijal S, Soto A, Menten J, Boelaert M, 2006. A meta-analysis of the diagnostic performance of the direct agglutination test and rk39 dipstick for visceral leishmaniasis. BMJ 333: 723-726. (Pubitemid 44555168)
18. Wilson JM, Juenger G, 1968. Principles and practice of screening for disease. Geneva: World Health Organization, Public Health Papers No. 34.
19. World Health Organization, 2003. Leprosy elimination campaigns: impact on case detection. Wkly Epidemiol Rec 78: 9-16.
20. Napier LE, Das Gupta CR, 1930. A clinical study of post kala-azar dermal leishmaniasis. Ind Med Gaz 63: 249-257.
21. Thakur CP, 1984. Epidemiological, clinical and therapeutic features of Bihar kala-azar (including post kala-azar dermal leishmaniasis). Trans R Soc Trop Med Hyg 78: 391-398.